반응식
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:13]=[CH:12][C:11]([C:14](=[O:16])[CH3:15])=[CH:10][CH:9]=2)=[CH:4][N:3]=1.[CH:17]([N:20]1[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]1)([CH3:19])[CH3:18]>>[ClH:1].[ClH:1].[CH:17]([N:20]1[CH2:25][CH2:24][N:23]([C:2]2[N:3]=[CH:4][C:5]([C:8]3[CH:13]=[CH:12][C:11]([C:14](=[O:16])[CH3:15])=[CH:10][CH:9]=3)=[CH:6][CH:7]=2)[CH2:22][CH2:21]1)([CH3:19])[CH3:18]참가 물질
3
실험 절차
The title compound was prepared by a similar procedure to that described in Example 1, starting from 2-chloro-5-(4-acetylphenyl)pyridine and 1-isopropylpiperazine.
출처 및 근거
- ORD 기록
- ord-26f6343d85ff4418972b83cf00947e9c
- 출처 데이터셋
- uspto-grants-2013_08
- 특허 번호
- US08501739B2
연결된 노트
불러오는 중…